|
04-01-2010, 04:05 AM
|
|||
|
|||
Press Release
pSivida Corp, (NASDAQ:PSDV, ASX:PSD, FF:PV33), a leader in the development of ophthalmic sustained release drug delivery products, with two of the only three such products approved by the FDA for treatment of back of the eye diseases, today announced it will be presenting at the Cowen & Company Annual Health Care Conference in Boston, March 8. Dr. Paul Ashton, president and chief executive ...
    
|
 |
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Press Release | cancerfr | Melanoma | 0 | 09-30-2010 02:52 AM |
| Press Release | cancerfr | Adrenocortical Carcinoma | 0 | 07-28-2010 03:16 PM |
| Press Release | cancerfr | Liver Cancer | 0 | 06-07-2010 07:43 PM |
| Press Release | cancerfr | Pheochromocytoma | 0 | 06-07-2010 07:43 PM |
| Press Release | cancerfr | Vaginal Cancer | 0 | 06-07-2010 07:43 PM |
Linear Mode
